Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet function disorders.

A D Shapiro1

  • 1Indiana Hemophilia and Thrombosis Center, Indianapolis, USA.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive Intra-Abdominal Pseudotumor in a Patient With Hemophilia A Treated With Emicizumab: A Case Report.

Clinical case reports·2026
Same author

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.

Blood advances·2020
Same author

The future of bypassing agents for hemophilia with inhibitors in the era of novel agents.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Optimizing bleed prevention throughout the lifespan: Womb to Tomb.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Clinical and laboratory phenotype variability in type 2M von Willebrand disease.

Journal of thrombosis and haemostasis : JTH·2017
Same journal

Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Use of an Oral Health-Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Utilisation and Perceived Value of Genetic Counsellors Within US Haemophilia Treatment Centres.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Correction to "Reference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry".

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Monitoring of Coagulation Potential of Efanesoctocog Alfa in Haemophilia A: Insights From Conventional and Global Hemostasis Assays.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles

Platelet function defects cause bleeding disorders, often presenting as bruising or surgical hemorrhage. Current treatments are limited, focusing on factor replacement and supportive therapies.

Area of Science:

  • Hematology
  • Biochemistry
  • Molecular Biology

Background:

  • Platelet function defects are a diverse group of bleeding disorders with variable severity.
  • Patients often experience easy bruising, mucocutaneous bleeding, or excessive hemorrhage after injury or surgery.
  • Understanding platelet biochemical pathways and structure is crucial for uncovering defect mechanisms.

Purpose of the Study:

  • To review the current understanding of platelet function defects.
  • To discuss the limitations and available treatment strategies for these disorders.

Main Methods:

  • Review of existing literature on platelet function defects.
  • Analysis of current therapeutic approaches including factor replacement, adjunctive therapies, and corticosteroids.

Related Experiment Videos

Main Results:

  • Despite advances in understanding etiology, treatment options remain limited.
  • Factor replacement is standard for disorders involving plasma coagulation factors like von Willebrand disease (vWD) and afibrinogenemia.
  • Adjunctive therapies, DDAVP/Stimate, platelet transfusions, and corticosteroids are mainstays of management.

Conclusions:

  • Further research into platelet biochemistry and structure is needed to uncover defect mechanisms.
  • Current treatments for platelet function defects are rudimentary, relying heavily on factor replacement and supportive measures.
  • Corticosteroids show potential in managing specific defects, particularly storage pool and release defects unresponsive to other treatments.